Signaling through JAM-1 and αvβ3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and αvβ3 complex

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Blood

• Publication date

  2003-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2003-04-1114
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of Angiogenesis and Tumor Growth by Sch221153, Updated Version Cited Articles Citing Articles E-mail Alerts Inhibition of Angiogenesis and Tumor Growth by Sch221153, a Dual ␣ V ␤ 3 and ␣ V ␤ 5 Integrin Receptor Antagonist

  2013cited by this paper
• Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells.

  2002cited by this paper
• Get a ligand, get a life: integrins, signaling and cell survival

  2002cited by this paper
• Integrin-mediated death: An explanation of the integrin-knockout phenotype?

  2002cited by this paper
• JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes

  2002cited by this paper
• Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

  2002cited by this paper
• Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma Does not reduce leukocyte transmigration under flow.

  2001cited by this paper
• VEGF transiently disrupts gap junctional communication in endothelial cells.

  2001cited by this paper
• Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members.

  2001cited by this paper
• Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials.

  2001cited by this paper
• Characterization and chromosomal localization of JAM-1, a platelet receptor for a stimulatory monoclonal antibody.

  2001cited by this paper
• Demonstration of inhibitory effect of oral shark cartilage on basic fibroblast growth factor-induced angiogenesis in the rabbit cornea.

  2001cited by this paper
• Interaction of endostatin with integrins implicated in angiogenesis.

  2001cited by this paper
• Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3.

  2000cited by this paper
• Normal Development, Wound Healing, and Adenovirus Susceptibility in β5-Deficient Mice

  2000cited by this paper
• Human junction adhesion molecule regulates tight junction resealing in epithelia.

  2000cited by this paper
• Role of alpha v integrins during angiogenesis.

  2000cited by this paper
• Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist

  1999cited by this paper
• Anchorage-dependent Regulation of the Mitogen-activated Protein Kinase Cascade by Growth Factors Is Supported by a Variety of Integrin α Chains*

  1999cited by this paper
• In Vitro Models of Angiogenesis: The use of Matrigel

  1999cited by this paper
• Integrins in vascular development.

  1999cited by this paper
• Roles of Extracellular Signal‐regulated Kinase 1/2 and p38 Mitogen‐activated Protein Kinase in the Signal Transduction of Basic Fibroblast Growth Factor in Endothelial Cells during Angiogenesis

  1999cited by this paper
• Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells.

  1999cited by this paper
• Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.

  1999cited by this paper
• Radiolabeled αvβ3 Integrin Antagonists: A New Class of Tracers for Tumor Targeting

  1999cited by this paper
• Junctional Adhesion Molecule, a Novel Member of the Immunoglobulin Superfamily That Distributes at Intercellular Junctions and Modulates Monocyte Transmigration

  1998cited by this paper
• Vascular Permeability Factor/Vascular Endothelial Cell Growth Factor-mediated Permeability Occurs through Disorganization of Endothelial Junctional Proteins*

  1998cited by this paper
• Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All αv Integrins

  1998cited by this paper
• A Peptidomimetic Antagonist of the Integrin αvβ3 Inhibits Leydig Cell Tumor Growth and the Development of Hypercalcemia of Malignancy

  1998cited by this paper
• Integrin αvβ3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during Angiogenesis

  1998cited by this paper
• Angiogenesis and angiogenesis inhibition: an overview.

  1997cited by this paper
• Biological roles of fibroblast growth factor-2.

  1997cited by this paper
• Identification of a Novel Calcium-binding Protein That Interacts with the Integrin αIIb Cytoplasmic Domain*

  1997cited by this paper
• Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

  1996cited by this paper
• Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane.

  1995cited by this paper
• An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization.

  1995cited by this paper
• Alteration of collagen-dependent adhesion, motility, and morphogenesis by the expression of antisense alpha 2 integrin mRNA in mammary cells.

  1995cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Definition of Two Angiogenic Pathways by Distinct αv Integrins

  1995cited by this paper
• Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

  1994cited by this paper
• Requirement of vascular integrin alpha v beta 3 for angiogenesis.

  1994cited by this paper

• Mechanoresponsive ion channels Piezo1 and TRPV4 stimulate ADAM10 and ADAM17 with differential impact on endothelial migration and proliferation

  2026cites this paper
• Junctional adhesion molecule-C: A multifunctional mediator of cell adhesion

  2025cites this paper
• JAM-A: Adhesion Receptor and Signaling Regulator in Atherosclerosis

  2025cites this paper
• JAM-A Overexpression in Human Umbilical Cord-Derived Mesenchymal Stem Cells Accelerated the Angiogenesis of Diabetic Wound By Enhancing Both Paracrine Function and Survival of Mesenchymal Stem Cells

  2023cites this paper
• F11R/JAM-A: why do platelets express a molecule which is also present in tight junctions?

  2023cites this paper
• Ocular immune privilege and retinal pigment epithelial cells.

  2023cites this paper
• Retraction: Role of alternative splicing of VEGF-A in the development of atherosclerosis.

  2023cites this paper
• Pathophysiological roles of integrins in gliomas from the perspective of glioma stem cells

  2022cites this paper
• In vitro assessment of varying peptide surface density on the suppression of angiogenesis by micelles displaying αvβ3 blocking peptides

  2022cites this paper
• Junctional Adhesion Molecules: Potential Proteins in Atherosclerosis

  2022cites this paper
• JAM-A interacts with α3β1 integrin and tetraspanins CD151 and CD9 to regulate collective cell migration of polarized epithelial cells

  2022cites this paper
• The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression

  2021cites this paper
• Henry Ford Health System

  2020cites this paper
• Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell–Cell Interactions in Tumor Progression

  2020cites this paper
• Targeting Opposing Immunological Roles of the Junctional Adhesion Molecule-A in Autoimmunity and Cancer

  2020cites this paper
• Dual role of Jam3b in early hematopoietic and vascular development

  2019influential citation
• Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growth.

  2019cites this paper
• Phosphorylation of tight junction transmembrane proteins: Many sites, much to do

  2018cites this paper
• Junctional Adhesion Molecules (JAMs): The JAM-Integrin Connection

  2018cites this paper
• Role of ATP during the initiation of microvascularization: acceleration of an autocrine sensing mechanism facilitating chemotaxis by inorganic polyphosphate.

  2018cites this paper
• JAM-A knockdown accelerates the proliferation and migration of human keratinocytes, and improves wound healing in rats via FAK/Erk signaling

  2018cites this paper
• Junctional adhesion molecule-A: functional diversity through molecular promiscuity

  2018cites this paper
• A novel immunotoxin reveals a new role for CD321 in endothelial cells

  2017cites this paper
• Junctional adhesion molecule A: expression in the murine epididymal tract and accessory organs and acquisition by maturing sperm

  2017cites this paper
• Elevated expression of JAM‐A promotes neoplastic properties of lung adenocarcinoma

  2017cites this paper
• Junctional Adhesion Molecules (JAMs): Cell Adhesion Receptors With Pleiotropic Functions in Cell Physiology and Development.

  2017cites this paper
• Blood Vascular Endothelial Adhesion Molecules

  2016cites this paper
• ANGPTL4–αvβ3 interaction counteracts hypoxia‐induced vascular permeability by modulating Src signalling downstream of vascular endothelial growth factor receptor 2

  2016cites this paper
• Neutrophil-Epithelial Interactions: A Double-Edged Sword.

  2016cites this paper
• Endothelial Cell Junctional Adhesion Molecules: Role and Regulation of Expression in Inflammation

  2016cites this paper
• Morphological and Functional Properties of the Blood-Brain Barrier

  2015cites this paper
• RNA interference mediated JAM-A gene silencing promotes human epidermal stem cell proliferation

  2015cites this paper
• JAM-C promotes lymphangiogenesis and nodal metastasis in non-small cell lung cancer

  2014cites this paper
• Effects of integrins and integrin αvβ3 inhibitor on angiogenesis in cerebral ischemic stroke

  2014cites this paper
• JAM-related proteins in mucosal homeostasis and inflammation

  2014cites this paper
• Tight junction dynamics: the role of junctional adhesion molecules (JAMs)

  2014cites this paper
• JAM-A: Junctional Adhesion Molecule-A or Janus Acting Mediator in atherosclerosis

  2014cites this paper
• for long-term repopulating hematopoietic stem cells Junctional adhesion molecule-A, JAM-A, is a novel cell-surface marker

  2013cites this paper
• Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor–specific angiogenic signaling

  2013cites this paper
• Function of Junctional Adhesion Molecules (JAMs) in Leukocyte Migration and Homeostasis

  2013cites this paper
• Comparative Pharmacodynamic Assessment of the Antiangiogenesis Activity of Heparin and Low-Molecular-Weight Heparin Fractions

  2013cites this paper
• DICAM inhibits angiogenesis via suppression of AKT and p38 MAP kinase signalling.

  2013cites this paper
• inflammation JAM-C regulates unidirectional monocyte transendothelial migration in

  2013cites this paper
• Tight Junctions, Junctional Adhesion Molecules (JAMs), and the Blood Brain Barrier

  2013cites this paper
• Junctional Adhesion Molecule-A Regulates Vascular Endothelial Growth Factor Receptor-2 Signaling-Dependent Mouse Corneal Wound Healing

  2013cites this paper
• Overexpression of JAM-A in Non-Small Cell Lung Cancer Correlates with Tumor Progression

  2013cites this paper
• Differential expression of junctional adhesion molecules in different stages of systemic sclerosis.

  2013influential citation
• JAM-A protects from thrombosis by suppressing integrin αIIbβ3-dependent outside-in signaling in platelets.

  2012cites this paper
• Angiogenesis and Vasculopathy in Systemic Sclerosis: Evolving Concepts

  2012cites this paper
• Genomic Organisation, Embryonic Expression and Biochemical Interactions of the Zebrafish Junctional Adhesion Molecule Family of Receptors

  2012cites this paper
• Transforming growth factor-β1 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasion.

  2012cites this paper
• Recent developments in adhesion in rheumatoid arthritis

  2012cites this paper
• JAMming the signals.

  2012cites this paper
• Neuroprotective roles of the P2Y2 receptor

  2012cites this paper
• Essential role of interleukin-6 in post-stroke angiogenesis.

  2012cites this paper
• CASK interacts with PMCA4b and JAM‐A on the mouse sperm flagellum to regulate Ca2+ homeostasis and motility

  2012cites this paper
• Low Expression of Junctional Adhesion Molecule A Is Associated with Metastasis and Poor Survival in Pancreatic Cancer

  2012cites this paper
• Junctional Adhesion Molecules (JAMs) - New Players in Breast Cancer?

  2011influential citation
• Pathobiology of Junctional Adhesion Molecules

  2011cites this paper
• Die Expression von Junctional Adhesion Molecule-A auf humanen CD34 + Zellen fördert deren Adhäsion und Differenzierung zu endothelialen Progenitorzellen

  2011cites this paper
• Morphology and properties of brain endothelial cells.

  2011cites this paper
• Review: Molecular pathogenesis of blood–brain barrier breakdown in acute brain injury

  2011cites this paper
• Junctional adhesion molecule-A prevents cardiac rupture following myocardial infarction

  2011cites this paper
• Disruption of central nervous system barriers in multiple sclerosis.

  2011cites this paper
• Distribution of the Feline Calicivirus Receptor Junctional Adhesion Molecule A in Feline Tissues

  2011cites this paper
• T Lymphocyte Infiltration Antitumoral Immune Response by Promoting Dendritic Cell Inactivation of Junctional Adhesion Molecule-A Enhances

  2010cites this paper
• A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions

  2010cites this paper
• Inactivation of junctional adhesion molecule-A enhances antitumoral immune response by promoting dendritic cell and T lymphocyte infiltration.

  2010cites this paper
• Stimulation of Wound Revascularization by Adenosine Receptor Activation

  2010cites this paper
• CRTAM: A molecule involved in epithelial cell adhesion

  2010cites this paper
• Tight junctions in the testis: new perspectives

  2010cites this paper
• Mediator of Angiogenesis Junctional Adhesion Molecule-C Is a Soluble

  2010cites this paper
• Junctional Adhesion Molecules (JAMs)

  2010cites this paper
• Junctional Adhesion Molecule-C Is a Soluble Mediator of Angiogenesis

  2010cites this paper
• Regulation of angiogenesis by a small GTPase Rap1.

  2010cites this paper
• Junctional adhesion molecule-A is abnormally expressed in diffuse cutaneous systemic sclerosis skin and mediates myeloid cell adhesion

  2009cites this paper
• JAM-C Induces Endothelial Cell Permeability Through Its Association and Regulation of &bgr;3 Integrins

  2009cites this paper
• adhesion sclerosis skin and mediates myeloid cell expressed in diffuse cutaneous systemic Junctional adhesion molecule-A is abnormally

  2009cites this paper
• JAM-A promotes neutrophil chemotaxis by controlling integrin internalization and recycling

  2009cites this paper
• Junctional adhesion molecule A interacts with Afadin and PDZ-GEF2 to activate Rap1A, regulate beta1 integrin levels, and enhance cell migration.

  2009cites this paper
• The role of cell adhesion pathways in angiogenesis.

  2009cites this paper
• [Endothelial cell-cell junctions in vessel formation].

  2009cites this paper
• The functional role of cell adhesion molecules in tumor angiogenesis.

  2009cites this paper
• Coxsackie- and adenovirus receptor (CAR) is expressed in lymphatic vessels in human skin and affects lymphatic endothelial cell function in vitro.

  2009cites this paper
• Structural determinants of Junctional Adhesion Molecule A (JAM-A) function and mechanisms of intracellular signaling.

  2009cites this paper
• JAM‐A expression positively correlates with poor prognosis in breast cancer patients

  2009cites this paper
• Mechanisms of Outside‐in Signaling at the Tight Junction by Junctional Adhesion Molecule A

  2009cites this paper
• Adenosine receptor agonists for promotion of dermal wound healing.

  2009cites this paper
• Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium.

  2008cites this paper
• A comparative molecular force spectroscopy study of homophilic JAM‐A interactions and JAM‐A interactions with reovirus attachment protein σ1

  2008cites this paper
• Putting the brakes on cancer cell migration

  2008cites this paper
• Contributing Factor for Breast Cancer Cell Invasion Attenuation of Junctional Adhesion Molecule-A Is a

  2008cites this paper
• Adhesion molecules in the vascular cell cross-talk

  2008cites this paper
• Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion.

  2008cites this paper
• Junctional adhesion molecule-A, JAM-A, is a novel cell-surface marker for long-term repopulating hematopoietic stem cells.

  2008cites this paper
• Junctional adhesion molecule -A and reovirus pathogenesis

  2008cites this paper
• Decreased junctional adhesion molecule-A expression during blood–brain barrier breakdown

  2008cites this paper
• Cis-dimerization mediates function of junctional adhesion molecule A.

  2008cites this paper
• JAM-A is both essential and inhibitory to development of hepatic polarity in WIF-B cells.

  2008cites this paper
• Endothelial-Dependent Mechanisms of Leukocyte Recruitment to the Vascular Wall

  2007cites this paper